Speaker: Jie Jack Li, PhD has practiced medicinal chemistry since 1997 at Pfizer, BMS, and Revolution Medicines, respectively, with a four-year sojourn at the University of San Francisco as an Associate Professor, teaching organic and medicinal chemistry. He is currently a vice president of Discovery Chemistry at ChemPartner, splitting his time between San Francisco and...
COVID-19 has ignited biotech and digital health investment activity – from telemedicine to drug trial technology to precision genomics. In 2020, biotech IPO’s continued to pique investor interest and venture capital fundraising in healthcare reached record levels- and 2021 shows no sign of abating. According to Crunchbase, there has been $4.1B+ in health-related investment deals this year...
Join us for this FREE, virtual event! Randall Hyer, MD, PhD, MPH Senior Vice President at Moderna Therapeutics, Inc. will be presenting on the topic "The Beginning and End of COVID-19." This event is free of charge but pre-registration is required.
How do you turn great science into a great business? By pooling the efforts and expertise of talented individuals. During this panel we’ll explore how to: • Identify and prioritize the skills and expertise needed to grow a life science business • Strategies for finding and attracting the right hires • Creative approaches to tapping...
This meeting is one of many screening forums organized by SoCalBio to select the best device, biotech, and digital health company candidates to make presentations during: The 23rd Annual SoCalBio Conference on October 20-22, 2021 5th SoCalBio Digital Health Conference on March 23-25, 2022
Life Sciences Future – MedTech will be held over a 3-day period using a robust web-based platform that includes both live and on demand features. All company presentations will be pre-recorded and loaded into the platform prior to the event. The conference will include the most popular conference features, but will focus on various topics...
Although there has been a gradual change over the past 20 years in the recognition and public acceptance of the importance of mental health problems, there is a persistent translational gap between preclinical research and psychiatric treatment. Novel strategies are being implemented to utilise technology and AI to detect, monitor, and treat mental health issues....
Are you looking to improve the performance of your peptide drug products? Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions. The 2021 Peptide Drug Design & Delivery Summit will bring together key decision-makers and innovators within this rapidly growing field. This intensive 2-Day program...
How can you ramp up your new employee experience by implementing inclusive onboarding and transition practices at your organization? Join Slone Partners and Biocom California for a timely interactive discussion where we will share best practices and tangible tools to help your organization develop an inclusive experience to onboard and retain top talent. The extent...
Join Biocom California and the City of Fremont on July 21st to hear from a panel of industry leaders on why life science is booming in Fremont, initiatives to recruit local talent, the industry's evolution, and how companies in Fremont will contribute to future life science growth in the Bay Area.
For decades now, X-ray crystallography has been the go-to technique to unravel structural details of proteins, in pursuit of answering various biological questions and aiding structure based drug design. However, in the last few years, cryo-Electron Microscopy (cryoEM) has garnered a lot of attention and is quickly advancing towards being the most effective and powerful...
Join us for a unique networking event, which is free of charge, to watch ‘Shark-Tank’ style pitches from three new startup companies located at the Pennsylvania Biotechnology Center (PABC), followed by breakout sessions for each company. The three companies are: (1) EcoGenome, a life science company dedicated to the development of prognostic and predictive tests...
